Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 56 results for "cameron hodgkins"

Obinutuzumab, bendamustine significantly extend PFS in relapse...

CHICAGO The addition of the monoclonal antibody obinutuzumab to standard bendamustine chemotherapy significantly delayed the progression of relapsed indolent non-Hodgkin's lymphoma, according to the results of an open-label phase 3 study presented ... Orthopedics Today, 1 month ago

Marni Hodgkin: Editor known for her integrity and her bestsellers, who helped to transform the world of children's books in the 1960s and 70s

Buhari can't transform 8 yrs rot overnight Obasanjo Vanguard (Today) - He knows what we did to turn things around, even when we were there together during the military regime, we did it together, and it was as a result of... Buhari Will Perform ...
 NigerianHerald.com1 month ago

Over 80s are honored

Missed out on the latest golf news? Not any more … Join us as we regularly update the latest briefs, quotes, tidbits and global golfing gold. Welcome to Bump and Run. Fifteen members at Harrington Waters Golf Club on the New South Wales ...
 Noodls11 hours ago Honor for familiar figure  Noodls3 weeks ago

HIV increases risk for death from common cancers

Patients with cancer who are HIV-infected experienced significantly higher cancer mortality rates compared with patients without HIV, according to study results. Mortality remained higher among patients with HIV regardless of cancer stage or ...
 Orthopedics Today4 days ago Out of options, cancer patients respond well to Seattle company's experimental therapy  Fred Hutch1 month ago Gastrointestinal stromal tumors increase risk for additional malignancies  Orthopedics Today1 month ago

Thousands celebrate Armed Forces Day

Marking its 7th year, events have ranged from large scale parades to simple community events, but the main focus of attention was at the National Event in Guildford, attended by His Royal Highness The Duke of York. The Prime Minister David Cameron ...
 Noodls1 week ago News story: Thousands celebrate Armed Forces Day  Bloomberg1 week ago

TUC - Risks 708 - 27 June 2015

Risks is the TUC's weekly online bulletin for safety reps and others. Sign up to receive this bulletin every week. Past issues are available. Disclaimer and Privacy Editor: Rory O'Neill of Hazards magazine. Comments to the TUC at [email protected] ...
 Trades Union Congress1 week ago

Noninvasive prenatal testing may detect presymptomatic cancers in pregnant women

Maternal plasma cell-free DNA sequencing for noninvasive prenatal testing could lead to the detection of presymptomatic maternal tumors and treatment during pregnancy, according to a case report published in JAMA Oncology . Noninvasive prenatal ...
 Orthopedics Today2 weeks ago

Lower dose of polatuzumab vedotin safe, effective for follicular lymphoma

CHICAGO — A lower dose of polatuzumab vedotin combined with rituximab yielded comparable overall response rates as a higher dose yet improved toxicity among patients with relapsed or refractory follicular lymphoma, according to study results ...
 Orthopedics Today1 month ago

Chemotherapy-free triplet therapy appears safe, effective for B-cell malignancies

CHICAGO — A chemotherapy-free triplet composed of ublituximab, TGR-1202 and ibrutinib demonstrated significant early activity and tolerability in patients with heavily pre-treated or high-risk B-cell malignancies, according to study results ...
 Orthopedics Today1 month ago

Juno Therapeutics Reports JCAR014 Showed 'Encouraging' Clinical Responses, Translational Insights in Patients with B-Cell Cancers

Juno Therapeutics, Inc. announced today that clinical data from a chimeric antigen receptor (CAR) T cell product candidate, JCAR014, demonstrated encouraging clinical responses in patients with B-cell cancers. Clinical results will be presented in ...
 Benzinga.com1 month ago Juno's Investigational CAR T Cell Product Candidate JCAR014 Demonstrates Encouraging Clinical Responses and Translational Insights in Patients With B-Cell Cancers  CEOWorld Magazine1 month ago Fred Hutch researchers present at ASCO 2015 Annual meeting  Fred Hutch1 month ago ASCO15: Juno Therapeutics's Investigational CAR T Cell Product Candidate JCAR014 Demonstrates Encouraging Clinical Responses And Translational Insights In Patients With B-Cell Cancers  BioSpace1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less